{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T11:06:42Z","timestamp":1785236802081,"version":"3.55.0"},"reference-count":31,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81872832"],"award-info":[{"award-number":["81872832"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82073806"],"award-info":[{"award-number":["82073806"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Chromatography A"],"published-print":{"date-parts":[[2021,6]]},"DOI":"10.1016\/j.chroma.2021.462147","type":"journal-article","created":{"date-parts":[[2021,4,15]],"date-time":"2021-04-15T22:20:48Z","timestamp":1618525248000},"page":"462147","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["Development of acidic phospholipid containing immobilized artificial membrane column to predict drug-induced phospholipidosis potency"],"prefix":"10.1016","volume":"1647","author":[{"given":"Jincai","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xianglong","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongsheng","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liang","family":"Lai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1001-1873","authenticated-orcid":false,"given":"Jacques","family":"Crommen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jialiang","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5612-4331","authenticated-orcid":false,"given":"Zhengjin","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.chroma.2021.462147_bib0001","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1517\/14740338.5.4.567","article-title":"Drug-induced phospholipidosis: issues and future directions","volume":"5","author":"Reasor","year":"2006","journal-title":"Expert Opin. Drug Saf."},{"key":"10.1016\/j.chroma.2021.462147_bib0002","first-page":"454","article-title":"Chloroquine (SN-7618) pathologic changes observed in rats which for 2 years had been fed various proportions","volume":"45","author":"Nelson","year":"1948","journal-title":"Arch. Pathol."},{"key":"10.1016\/j.chroma.2021.462147_bib0003","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/S0022-3565(25)03265-3","article-title":"The chronic oral toxicity of chloroquine","volume":"93","author":"Fitzhugh","year":"1948","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.chroma.2021.462147_bib0004","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/0041-008X(89)90061-6","article-title":"Amiodarone-induced pulmonary toxicity in rats: biochemical and pharmacological characteristics","volume":"97","author":"Reasor","year":"1989","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.chroma.2021.462147_bib0005","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1080\/01926230701196414","article-title":"Phospholipidosis in nonclinical toxicity studies","volume":"35","author":"Berridge","year":"2007","journal-title":"Toxicol. Pathol."},{"key":"10.1016\/j.chroma.2021.462147_bib0006","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1177\/0192623309348521","article-title":"Phospholipidosis in neurons caused by posaconazole, without evidence for functional neurologic effects","volume":"37","author":"Cartwright","year":"2009","journal-title":"Toxicol. Pathol."},{"key":"10.1016\/j.chroma.2021.462147_bib0007","doi-asserted-by":"crossref","first-page":"3761","DOI":"10.1016\/0006-2952(86)90662-3","article-title":"Binding of propranolol and gentamicin to small unimellar phospholipid vesicles: contribution of ionic and hydrophobic forces","volume":"35","author":"Kubo","year":"1986","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.chroma.2021.462147_bib0008","first-page":"347","article-title":"Use of physicochemical calculation of pKa and CLogP to predict phospholipidosis-inducing potential: a case study with structurally related piperazines","volume":"55","author":"Ploemen","year":"2004","journal-title":"Exp. Toxicol. Pathol."},{"key":"10.1016\/j.chroma.2021.462147_bib0009","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1021\/ci6004542","article-title":"Evaluation of a published in silico model and construction of a novel Bayesian model for predicting phospholipidosis inducing potential","volume":"47","author":"Pelletier","year":"2007","journal-title":"J. Chem. Inf. Model."},{"key":"10.1016\/j.chroma.2021.462147_bib0010","doi-asserted-by":"crossref","first-page":"315","DOI":"10.2131\/jts.31.315","article-title":"Physicochemical and cell-based approach for early screening of phospholipidosis-inducing potential","volume":"31","author":"Tomizawa","year":"2006","journal-title":"J. Toxicol. Sci."},{"key":"10.1016\/j.chroma.2021.462147_bib0011","doi-asserted-by":"crossref","first-page":"3674","DOI":"10.1002\/elps.200800236","article-title":"A method for rapidly predicting drug tissue distribution using surfactant vesicle electrokinetic chromatography","volume":"29","author":"Jiang","year":"2008","journal-title":"Electrophoresis"},{"key":"10.1016\/j.chroma.2021.462147_bib0012","doi-asserted-by":"crossref","first-page":"6980","DOI":"10.1021\/ac200683k","article-title":"Predicting phospholipidosis: a fluorescence noncell based in vitro assay for the determination of drug\u2013phospholipid complex formation in early drug discovery","volume":"83","author":"Zhou","year":"2011","journal-title":"Anal. Chem."},{"key":"10.1016\/j.chroma.2021.462147_bib0013","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.chroma.2014.09.048","article-title":"A novel mixed phospholipid functionalized monolithic column for early screening of drug induced phospholipidosis risk","volume":"1367","author":"Zhao","year":"2014","journal-title":"J. Chromatogr. A"},{"key":"10.1016\/j.chroma.2021.462147_bib0014","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.jchromb.2017.02.024","article-title":"Hydrophilic interaction chromatography with a focus on the drug-phosphate interaction in drug screening to determine the phospholipidosis induction risk","volume":"1051","author":"Okamoto","year":"2017","journal-title":"J. Chromatogr. B"},{"key":"10.1016\/j.chroma.2021.462147_bib0015","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1016\/j.tiv.2006.05.009","article-title":"Improved toxicogenomic screening for drug-induced phospholipidosis using a multiplexed quantitative gene expression ArrayPlate assay","volume":"20","author":"Sawada","year":"2006","journal-title":"Toxicol. In Vitro"},{"key":"10.1016\/j.chroma.2021.462147_bib0016","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1007\/s10337-013-2621-5","article-title":"Phospholipid-modified ODS monolithic column for affinity prediction of hydrophobic basic drugs to phospholipids","volume":"77","author":"Kuroda","year":"2014","journal-title":"Chromatographia"},{"key":"10.1016\/j.chroma.2021.462147_bib0017","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1002\/elps.200500647","article-title":"Investigation of vesicle electrokinetic chromatography as an in vitro assay for the estimation of intestinal permeability of pharmaceutical drug candidates","volume":"27","author":"Pascoe","year":"2006","journal-title":"Electrophoresis"},{"key":"10.1016\/j.chroma.2021.462147_bib0018","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1023\/A:1024778329320","article-title":"A cell-based approach for the early assessment of the phospholipidogenic potential in pharmaceutical research and drug development","volume":"19","author":"Casartelli","year":"2003","journal-title":"Cell Biol. Toxicol."},{"key":"10.1016\/j.chroma.2021.462147_bib0019","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.jpba.2011.11.033","article-title":"Chromatography approaches for early screening of the phospholipidosis-inducing potential of pharmaceuticals","volume":"61","author":"Jiang","year":"2012","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.chroma.2021.462147_bib0020","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.jpba.2014.03.043","article-title":"Liposome electrokinetic chromatography based in vitro model for early screening of the drug-induced phospholipidosis risk","volume":"96","author":"Wang","year":"2014","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.chroma.2021.462147_bib0021","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1515\/hsz-2019-0270","article-title":"Emerging mechanisms of drug-induced phospholipidosis","volume":"401","author":"Breiden","year":"2019","journal-title":"Biol. Chem."},{"key":"10.1016\/j.chroma.2021.462147_bib0022","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1016\/j.bbalip.2012.08.013","article-title":"Drug induced phospholipidosis: an acquired lysosomal storage disorder","volume":"1831","author":"Shayman","year":"2013","journal-title":"Biochim. Biophys. Acta, Mol. Cell Biol. Lipids"},{"key":"10.1016\/j.chroma.2021.462147_bib0023","series-title":"Handbook of Lipid Bilayers","author":"Marsh","year":"2013"},{"key":"10.1016\/j.chroma.2021.462147_bib0024","doi-asserted-by":"crossref","first-page":"2606","DOI":"10.1194\/jlr.M054528","article-title":"Acid sphingomyelinase activity is regulated by membrane lipids and facilitates cholesterol transfer by NPC2","volume":"55","author":"Oninla","year":"2014","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.chroma.2021.462147_bib0025","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1042\/bj3041001","article-title":"Phosphatidic acid activation of protein kinase C-\u03b6 overexpressed in COS cells: comparison with other protein kinase C isotypes and other acidic lipids","volume":"304","author":"Limatola","year":"1994","journal-title":"Biochem. J."},{"key":"10.1016\/j.chroma.2021.462147_bib0026","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.chemphyslip.2010.03.001","article-title":"Synthesis, characterization and properties of a new polymerisable surfactant: 12-Methacryloyl dodecylphosphocholine","volume":"163","author":"Seuring","year":"2010","journal-title":"Chem. Phys. Lipids"},{"key":"10.1016\/j.chroma.2021.462147_bib0027","doi-asserted-by":"crossref","first-page":"6885","DOI":"10.1039\/c1cc11843a","article-title":"Phospholipids with a stimuli-responsive thermotropic liquid-crystalline moiety","volume":"47","author":"Kanie","year":"2011","journal-title":"Chem. Commun."},{"key":"10.1016\/j.chroma.2021.462147_bib0028","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1002\/(SICI)1521-4168(20000101)23:1<67::AID-JHRC67>3.0.CO;2-L","article-title":"Capillary Electrochromatography with Monolithic Poly (styrene-co-divinylbenzene-co-methacrylic acid) as the Stationary Phase","volume":"23","author":"Xiong","year":"2000","journal-title":"J. High Resolut. Chromatogr."},{"key":"10.1016\/j.chroma.2021.462147_bib0029","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1002\/1520-6017(200008)89:8<1085::AID-JPS13>3.0.CO;2-N","article-title":"Rapid-gradient HPLC method for measuring drug interactions with immobilized artificial membrane: comparison with other lipophilicity measures","volume":"89","author":"Valko","year":"2000","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.chroma.2021.462147_bib0030","doi-asserted-by":"crossref","first-page":"100891","DOI":"10.1039\/C6RA21504A","article-title":"Phosphatidic acid-functionalized monolithic stationary phase for reversed-phase\/cation-exchange mixed mode chromatography","volume":"6","author":"Peng","year":"2016","journal-title":"RSC Adv."},{"key":"10.1016\/j.chroma.2021.462147_bib0031","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.chroma.2015.06.056","article-title":"Preparation of a biomimetic polyphosphorylcholine monolithic column for immobilized artificial membrane chromatography","volume":"1407","author":"Zhao","year":"2015","journal-title":"J. Chromatogr. A"}],"container-title":["Journal of Chromatography A"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021967321002715?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021967321002715?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T17:57:47Z","timestamp":1762192667000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021967321002715"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6]]},"references-count":31,"alternative-id":["S0021967321002715"],"URL":"https:\/\/doi.org\/10.1016\/j.chroma.2021.462147","relation":{},"ISSN":["0021-9673"],"issn-type":[{"value":"0021-9673","type":"print"}],"subject":[],"published":{"date-parts":[[2021,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Development of acidic phospholipid containing immobilized artificial membrane column to predict drug-induced phospholipidosis potency","name":"articletitle","label":"Article Title"},{"value":"Journal of Chromatography A","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.chroma.2021.462147","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"462147"}}